Your session is about to expire
← Back to Search
Study Summary
This trial will attempt to identify if there is a relationship between vestibular signals and anxiety by studying the effects of two different drugs known to reduce the theta rhythm.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 40 years old.You have a history of drug or alcohol addiction, or someone in your family has a history of addiction.I have heart, lung disease, or diabetes.I have skin lesions in my ear canal.I have COPD or sleep apnea.I have kidney or liver problems.I am not taking antibiotics or supplements that affect CYP3A4 or CYP2D6.You are pregnant, breastfeeding, left-handed, or have difficulty seeing certain colors.I have been in psychological treatment or taken psychiatric drugs in the past year.You have had allergic reactions on your skin to things like soaps or cleaning products.You have not been diagnosed with any balance problems, as determined by a test performed by the doctor.I am currently experiencing symptoms similar to the flu or COVID-19.I am not taking any medications that could interfere with the study drugs.I am currently recovering from an accident, injury, or surgery.I have or had a neurological illness.I have a history of stroke, head injury, loss of consciousness, or epilepsy.
- Group 1: Triazolam
- Group 2: Buspirone
- Group 3: Placebo
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants have enrolled in this trial thus far?
"At this time, no further participants are being accepted. This research project was initially posted on January 1st 2023 and had its last update on October 31st 2022. If interested in other studies, there is a total of 374 trials recruiting patients with anxiety as well as 9 clinical studies requiring individuals for the administration of Triazolam 0.25 MG Oral Tablet."
Has the efficacy of Triazolam 0.25 MG Oral Tablet been explored in other research studies?
"At the current moment, there are 9 clinical trials that utilize Triazolam 0.25 MG Oral Tablets with none of them in Phase 3 status. Most locations for these studies are located in Tianjin but overall, nine sites across multiple regions have active research centers focused on this drug."
Is enrollment open for this experiment currently?
"The information posted on clinicaltrials.gov suggests that this medical investigation is not currently seeking participants, as the last update was made October 31st 2022. However, 383 other studies are actively enrolling patients right now."
Does this research endeavor allow for individuals aged 85 or above to participate?
"This clinical trial is recruiting participants with an age range of 18 to 40 years old."
Do I meet the qualifications for taking part in this investigation?
"This study is recruiting a cohort of 42 anxious individuals aged 18 and 40. To be eligible, participants must also meet the following requirements: both sexes between 18 to 40 years old."
Share this study with friends
Copy Link
Messenger